FDA Inspection 1040135 — North Carolina Center for Reproductive Medicine Inc (NCCRM)
The FDA completed an inspection of North Carolina Center for Reproductive Medicine Inc (NCCRM) on February 6, 2018 in Cary, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 6, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Cary, NC (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12492 | 21 CFR 1271.85(a) | Infection with communicable disease agents |
| 12496 | 21 CFR 1271.85(b)(2) | SOP for release; reactive for CMV |